The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukemia (AML) on the NHS in England.
Read more
bestallergymedicinehq.org
Home »
The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukemia (AML) on the NHS in England.
Read moreThe first saliva test for coronavirus 2019 (COVID-19) was approved Monday by the U.S. Food and Drug Administration. The test,
Read moreCannabis on the NHS: Marijuana-based drugs for epilepsy and multiple sclerosis are approved for use Children suffering with life-threatening forms
Read moreResearchers from Gero, Skolkovo Institute of Science and Technology (Skoltech), Moscow Institute of Physics and Technology (MIPT), and University of
Read moreA new treatment for people with multiple myeloma will now be available on the NHS in England. Daratumumab (Darzalex) was
Read more(HealthDay)—The use of robotically assisted surgical devices for breast removal and other cancer-related surgeries is not approved by the U.S.
Read moreTHURSDAY, Nov. 29, 2018 — Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults
Read more